【Molecular composition】：

【CAS】：183133-96-2

【source】：Cabazitaxel

【Certification】：—

【Spec】：Monohydrate

【DMF】：Available

【use】：

Cabazitaxel is a microtubule inhibitor indicated in combination with prednisone for the treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.